The v-myb-and v-ets-containing E26 retrovirus induces the proliferation of chicken neuroretina (CNR) 
The v-myb-and v-ets-containing E26 retrovirus induces the proliferation of chicken neuroretina (CNR) cells in minimal medium. Proliferation of E26 CNR cells is strongly stimulated by basic fibroblast growth factor (bFGF). The v-myb-containing avian myeloblastosis virus also induces the proliferation of infected CNR cells stimulated by bFGF. Both E26 CNR and avian myeloblastosis virus CNR cells are able to form colonies in soft agar in the presence of bFGF. This suggests that the v-myb product, a nuclear sequence-specific DNA-binding protein which activates gene expression in transient transfection assays, plays a role in the proliferative response of the infected CNR cells. To determine the structure-function relationships of p1359ag-myb-ets and p48v-mYb, we have used deletion mutants expressed in retroviral vectors and have analyzed their effect on CNR cell proliferation as well as their effect on the CNR cell response to bFGF. We show that v-ets is not required for bFGF stimulation but increases the proliferation of CNR cells in minimal medium. In the v-myb mutants, the gag sequences derived from the helper virus increase the potency of the myb gene. The carboxyl-terminal domain required for the growth and transformation of myeloid cells and needed for maximal trans-activation in transient DNA transfection assays in fibroblasts was not required for the growth and bFGF response of CNR cells. In contrast, the domain encompassing amino acids 240 to 301 (containing part of the transcriptional activation domain of v-myb) was absolutely required for the response of CNR cells to bFGF and could be functionally replaced by the carboxyl-terminal transcriptional activation domain of the VP16 protein of herpes simplex virus.
The v-myb oncogene was initially identified as the cellderived sequence of the avian myeloblastosis virus (AMV) that transforms exclusively myeloid cells (28, 35, 37) . The v-myb protein product, p48vmb, is a doubly truncated version of its normal cellular counterpart and contains viral amino acids at both its amino (6-amino-acid) and its carboxyl (11-amino-acid) termini (8, 15, 22) . The v-myb product is present within the cell nucleus, has short half-life, and possesses an intrinsic, sequence-specific DNA-binding activity (4, 6, 23, 27) . Several lines of evidence suggested that myb-related genes may control cellular differentiation through a direct regulation of gene expression. The level of c-myb decreases dramatically upon differentiation of immature myeloblasts, erythroleukemic cells, and neuroblastoma cells (11, 36, 41) . In addition, constitutive expression of c-myb prevented the differentiation of erythroleukemic cells (9) . In DNA transfection assays p48 -,yb can function as a transactivator of gene expression (19, 24, 30, 44) . To date three functional domains have been identified in the c-myb product: an amino-terminal DNA-binding domain, a transcriptional activation domain, and a negative regulatory domain (39) . These experiments also suggest that p48v-myb possesses 40% of the transcriptional activation potential of the c-myb protein and 75% of its transcriptional repression activity.
The v-myb gene is also present in the avian erythroblastosis virus E26. After infection with E26, chickens develop * Corresponding author. mixed leukemias involving both myeloid and erythroid lineages (29, 35) . The E26 retrovirus contains the v-myb-ets sequence fused in the same reading frame with the residual gag sequence (25, 32) . A unique 5.7-kb genomic RNA encodes the 135-kDa gag-myb-ets protein which is located in the nucleus (6, 23) ; 272 codons encode the retroviral gag portion, 283 codons encode the myb part, and 491 codons encode the ets domain (25, 32, 33) .
Mutants of E26 temperature sensitive for myeloblast transformation have been isolated (3). These mutants have been molecularly cloned, and a nonconservative mutation, located in the conserved v-myb DNA-binding sequence, was found to be responsible for the thermosensitive phenotype exhibited by the viruses (13, 26) . On the other hand, a deletion in the carboxy terminus of v-ets removing 26 amino acids from the ets protein abolished only the erythroid potential of the mutant virus (31) . These data suggest that the myb sequence is responsible for the E26-induced myeloid transformation and that the ets sequence may be additionally required for the erythroid potential of the virus. However, a single point mutation in the v-ets sequence has been shown to affect both erythroid and myelomonocytic cell differentiation (16) , suggesting a cooperation between these two sequences in the transforming potential of E26. The function of the ets domain is unknown, but c-ets-1 encodes transcription factors recognizing the PEA3 DNA motif and is able to cooperate with the c-fos and c-jun products for transcriptional activation in transient DNA transfection assays (42) .
Biological systems unrelated to the hemopoietic system (20) (Kenilworth, N.J.), and fungizone was from E. R. Squibb & Sons (Princeton, N.J.). Gelatinized dishes were coated with 0.2% gelatin in phosphate-buffered saline (PBS) overnight at 4°C. Bovine pituitary bFGF was purified as previously described (17) .
Viruses and molecular clones. AMV and its mutants (18, 19) as well as E26 mutants are shown in Fig. 1 . The various internal deletion mutants in v-ets were derived from the XJE26 as follows. The 3.5-kbp BamHI-SalI (partial digest) gag-myb-ets fragment of the XJE26 proviral DNA was subcloned into plasmid pKH47. This DNA was then partially digested by the restriction enzyme PvuII since the v-ets gene contains three in-frame PvuII sites, at positions 630, 1450, and 1740 (32) . Plasmid clones containing the expected deletions (630 to 1450 in mutant 3A and deletion 630 to 1740 in mutant 4A) were obtained by purification of the appropriate fragments by agarose gel electrophoresis followed by religation and transfection into HB101. We then used a unique XhoI site located in the gag gene and a unique HindIII site located in v-ets at position 1770, upstream of the more distal PvuII site. The XhoI-HindIII fragment of each clone was prepared and inserted into the XhoI-HindIII proviral DNA of the XJE26 to yield the XJE26 3A and 4A clones. LiNR8 resulted from a recombination between Rous-associated virus type 1 (RAV-1) and AMV and was isolated from AMV-infected pigmented retinas. This virus encodes a P68gag-,yb fusion protein. The corresponding provirus was molecularly cloned, and the junction between gag and myb was sequenced; in addition, the restriction enzyme map of the LiNR8 myb was found identical to that of AMV. The viruses used were obtained by cotransfection of the molecular clones DNA with pRAV-1 DNA onto CNR cells as previously described (1) .
Cell culture, growth assay, and soft agar cloning. nine (specific activity, 1,000 Ci mmol-P) ml-', lysed in radioimmunoprecipitation assay buffer, and immunoprecipitated as described previously (1) . Serums used were rabbit anti-ets serum, rabbit anti-myb (7), and rabbit anti-gag. Immunoprecipitated proteins were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and then by fluorography. (Fig. 2) . Thus, proliferation in this defined medium discriminates between normal and oncogene-expressing cells.
RESULTS
We serum-free medium (Fig. 3) . Primary cells responded positively to bFGF, increasing by threefold their final cell density (data not shown). Propagated normal cells or cells expressing helper virus did not proliferate in response to bFGF. CNR E26 cells were strongly responsive, and the bFGF effect was dose dependent (50% effective dose, 0.7 ng/ml). Similar results were obtained with the E26 mutants (Fig. 3) .
The myb gene product alone is responsible for the bFGF sensitivity of infected CNR cells. E26 and E26 bets induced similar responses in infected CNR cells. This suggested that the myb domain was essential in the response of the CNR cells to bFGF. Therefore, we tested the biological properties of the myb-containing AMV and mutants of this virus (Fig. 1) on CNR. Transfection of CNR with molecular clones as well as infection of these cells with the viral progeny resulted in the appearance of morphologically modified cells for the AMV wild type and the mutants LX4, LX3, D4, D3, and VP16. All these cells were much less fibroblastic and differed morphologically from E26 CNR cells. LX2 and LX1 CNR cells had a morphology similar to that of the helper virusinfected cells. In contrast to E26 CNR cells, AMV CNR cells did not proliferate when maintained in minimum medium (Fig. 2) . AMV CNR cells were also responsive to bFGF, but to a lesser extent than the E26 or E26 bets mutant CNR cells (Fig. 3) . The difference in the CNR response between AMV and E26 mutants could be due either to the gag sequence or to the residual ets sequence fused in frame with the myb product. Therefore, we tested the biological activity of a AMV mutant virus (LiNR8) which expresses a P68gag-myb fusion protein. This mutant, isolated from pigmented retinal epithelial cells, has been molecularly cloned and the junction between gag and myb has been sequenced (Fig. 1) resulted from a recombination event between RAV-1 and AMV, removing the neo gene from the NEO AMV (18) .
CNR cells infected with LiNR8 did survive, as well as AMV-infected cells, when maintained in minimal medium. However, while AMV cells hardly responded to bFGF, cells infected with LiNR8 responded to the growth factor as well as cells infected with E26. This suggests that, in that assay, the gag gene is able to increase the activity of the myb product.
We next analyzed the effect of bFGF on the CNR cells infected with AMV mutants in serum-free medium versus medium supplemented with 1% serum. This last condition was chosen because of the low proliferative potential, in serum-free medium, of v-myb-expressing cells. As shown in Fig. 4A , wild-type AMV, LX4, and LX3 responded to bFGF, while LX1 and LX2 did not respond to it even in the presence of 1% serum. This suggests that for bFGF response, a critical region of the myb product lies between amino acids 240 and 302 (18) (Fig. 1) . A second series of mutants confirmed these results. CNR cells transfected or infected with mutant D3, lacking amino acids 240 to 301, were totally unresponsive to bFGF, while CNR cells transfected or infected with mutant D4, which contained this domain, did respond to bFGF (Fig. 4B) . Mutant VP16 in which the transcriptional activation domain of VP16 protein of herpes simplex virus is linked to the amino-terminal domain of inactive D3 mutant also induces the CNR cells to respond to bFGF (Fig. 4B) .
Effects of bFGF on the anchorage-independent growth of infected cells. The ability of cells to grow under anchorageindependent conditions has been shown to correlate with transformation (21) . We therefore tested the ability of CNR cells to respond to bFGF when maintained in soft agar in the presence of serum-supplemented medium. As shown in Table 1 , none of the infected cells formed colonies in the absence of FGF, and helper-infected cells exposed to bFGF were unable to grow. In contrast, cells expressing myb-ets or various myb products did grow in soft agar when bFGF was present. As in monolayer culture, LX1, LX2, and D3 were unresponsive to bFGF. In addition, it was observed that colonies developing in the presence of bFGF were larger for E26-transfected CNR cells than for cells transfected with AMV. Protein products of mutant v-myb-ets and v-myb genes. To confirm that the expected proteins were found in CNR cells expressing mutant viruses, cells were labeled with [35S]methionine and lysates were immunoprecipitated with ets and myb antisera. As a control we also used gag antiserum. Results are shown in Fig. 5 . Comparable amounts of P135gag-myb-ets and mutant proteins were found in E26-, XJ E26 3A-, and XJ E26 4A-infected cells. Since the epitope recognized by the anti-ets serum lies downstream from the deletion site (14) , mutants proteins were immunoprecipitated with anti-myb and anti-ets antibodies.
The relative mobilities of the mutant v-myb proteins were consistent with their predicted molecular weights as previously published (18) . All of the v-myb mutant viruses tested produced nearly wild-type levels of stable protein products. In addition, anti-gag antibodies revealed similar amount of Pr76 RAV-1 product in each of the AMV mutant-infected CNR (Fig. SB, lanes 1 ). This suggests that the efficiency of the helper infection was equivalent in all experiments, consistent with the similar number of G418-resistant colonies found in each culture after selection. (42) . The PEA3 sequence is a nuclear target for transcription activation by nonnuclear oncogenes (43) . Therefore, the ets part of the P135 oncogenic protein of E26 may substitute for the signal transduction pathway which acts through the PEA3 motif and thereby activate genes required for cell growth in minimum medium. Alternatively, the ets sequence could modify the transactivation properties of the myb sequences and/or the nature of the myb-regulated genes.
The above results indicate that the v-myb product is able to confer bFGF responsiveness to the CNR cells. myb encodes a transcriptional activator containing an aminoterminal DNA-binding domain, a transcriptional activation domain, and a transcriptional negative regulation domain (39) . CNR cells expressing v-myb are not transformed but are able to grow in soft agar in the presence of bFGF, suggesting a cooperative effect between the myb functions and the bFGF signal transduction pathway. Previous studies of v-myb deletion and insertion mutants demonstrated that transformation of hemopoietic cells correlates with transactivation of gene expression (19, 24) . We have studied representative mutants in the CNR system (Fig. 6) 
